{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:44:06Z","timestamp":1773290646632,"version":"3.50.1"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Neuropsychopharm."],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1017\/s1461145706007322","type":"journal-article","created":{"date-parts":[[2007,2,12]],"date-time":"2007-02-12T03:43:38Z","timestamp":1171251818000},"page":"547","source":"Crossref","is-referenced-by-count":109,"title":["Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies?"],"prefix":"10.1093","volume":"10","author":[{"given":"Boris P.","family":"Sokolov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,2,12]]},"container-title":["The International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/10\/4\/547\/2163294\/10-4-547.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T01:59:02Z","timestamp":1503453542000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article-lookup\/doi\/10.1017\/S1461145706007322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,12]]},"references-count":0,"journal-issue":{"issue":"04","published-print":{"date-parts":[[2007,8]]}},"URL":"https:\/\/doi.org\/10.1017\/s1461145706007322","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,12]]}}}